Levi & Korsinsky Reminds Atara Biotherapeutics, Inc. Investors of the Ongoing Investigation into Potential Violations of Securities Laws – ATRA
NEW YORK CITY, NY / ACCESS Newswire / January 20, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Atara Biotherapeutics, Inc. ("Atara Biotherapeutics, Inc.") (NASDAQ:ATRA) concerning possible violations of federal securities laws. Atara issued a press release on January 16, 2025, announcing receipt of "a Complete Response Letter (CRL) […]